GlySure has developed an automatic system for continuous intravascular glucose monitoring of patients in hospital intensive care units (ICU). It is well established that effective control of glucose levels dramatically reduces a number of risks to ICU patients including sepsis, renal failure and death. The GlySure CGM System allows fast, easy, non-disruptive set-up and requires minimal maintenance throughout the length of patient stay. The system can accurately monitor for over 120 hours and includes a patented, automated calibration prior to use.